The Kable

The Kable

Share this post

The Kable
The Kable
💉 Eli Lilly and Verve target Lp(a); Astellas partners with Cullgen on protein degraders; Valneva retires manufacturing plant
Copy link
Facebook
Email
Notes
More
Friday Kable

💉 Eli Lilly and Verve target Lp(a); Astellas partners with Cullgen on protein degraders; Valneva retires manufacturing plant

#364 | Sandoz’s push for biosimilar adoption; Jell-O-like electrodes for medical devices; NHS brings back retirees

Ria's avatar
Vinod's avatar
Ria
and
Vinod
Jun 16, 2023
∙ Paid
1

Share this post

The Kable
The Kable
💉 Eli Lilly and Verve target Lp(a); Astellas partners with Cullgen on protein degraders; Valneva retires manufacturing plant
Copy link
Facebook
Email
Notes
More
Share

Hello and welcome to this week’s last edition of The Kable, where retired health professionals and retired vaccine plants are both looking for new purpose.

In the UK, the NHS is hoping to shorten long waiting lists by offering retired doctors the option to get back to work. Starting this autumn, retired doctors can sign themselves up on a new digital pla…

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 The Kable
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More